Session » Imaging of Rheumatic Diseases Poster II

Date: Monday, November 18, 2024

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2024

10:30AM-12:30PM: Abstract Number: 1959

A 3-arm, Randomized, Open-label, Parallel Active Controlled, Multicentre International Study to Compare the Response of Ultrasound-assessed Synovitis to Baricitinib, Alone and Combined with Methotrexate versus Etanercept in Rheumatoid Arthritis Patients

10:30AM-12:30PM: Abstract Number: 1975

Accurate Detection of Arthritis Using Hand-held Thermal Imaging and Machine Learning

10:30AM-12:30PM: Abstract Number: 1967

Advanced Imaging in the Evaluation of Lupus Arthritis: A Systematic Literature Review and Meta-Analysis

10:30AM-12:30PM: Abstract Number: 1976

Artificial Intelligence Analysis of HRCT Images Reflects Pulmonary Involvement in Systemic Sclerosis Interstitial Lung Disease

10:30AM-12:30PM: Abstract Number: 1965

Artificial Intelligence Assisted Interpretation of Lung Ultrasound Imaging for the Detection of Interstitial Lung Disease

10:30AM-12:30PM: Abstract Number: 1956

Artificial Intelligence Enhanced Analysis of Nailfold Capillaries by Dermatoscopy in Rheumatology Centers

10:30AM-12:30PM: Abstract Number: 1957

Assessing Left Ventricular Hemodynamic Forces in Systemic Sclerosis Patients: Pilot Study

10:30AM-12:30PM: Abstract Number: 1966

Comparison of a Dynamic Optical System with Physician Physical Assessment of PIP Joints of Systemic Lupus Erythematosus Patients

10:30AM-12:30PM: Abstract Number: 1964

Comparison of Knee Minimum Joint Space Width Measurements Using Deep Learning in Patients with Rheumatoid Arthritis and Osteoarthritis Undergoing Total Knee Arthroplasty

10:30AM-12:30PM: Abstract Number: 1963

Computer Vision on Standardized Smartphone Photographs as a Screening Tool for Inflammatory Arthritis of the Hand: Results from an Indian Patient Cohort

10:30AM-12:30PM: Abstract Number: 1968

Development and Validation of an Arthritis-Detection Algorithm Using Thermal Imaging in Adults and Children

10:30AM-12:30PM: Abstract Number: 1969

Harmonising Consensus and Reliability Studies in Musculoskeletal Ultrasound

10:30AM-12:30PM: Abstract Number: 1958

Hemodynamic Forces: A Novel Cardiac MRI Parameter to Assess Cardiac Involvement in Sarcoidosis Patients

10:30AM-12:30PM: Abstract Number: 1971

Identifying Educational Opportunities Through Examination of Referrals to Rheumatology Musculoskeletal US Clinic

10:30AM-12:30PM: Abstract Number: 1978

Insertional and Midportion Achilles Tendinopathy Have Differences in Presence of Calcifications and Neovascularization

10:30AM-12:30PM: Abstract Number: 1972

Quantifying Sjogren’s Disease Burden: UHFUS Evaluation of the Number and Severity of Involved Exocrine Gland

10:30AM-12:30PM: Abstract Number: 1973

Radioisotopic Synoviorthesis: Factors Associated with Good Response Evaluated by Ultrasound

10:30AM-12:30PM: Abstract Number: 1961

Salivary and Lacrimal Glands Ultrasonography in Systemic Lupus Erythematosus Patients

10:30AM-12:30PM: Abstract Number: 1974

The Impact of Concomitant Shoulder Osteoarthritis in Polymyalgia Rheumatica

10:30AM-12:30PM: Abstract Number: 1977

Three-dimensional Stereophotogrammetry Has Utility in Tracking Upper Eyelid Involvement and Overall Disease Worsening in Patients with Craniofacial Localized Scleroderma

10:30AM-12:30PM: Abstract Number: 1960

To Biopsy or Not to Biopsy: Imaging Features of Chronic Nonbacterial Osteomyelitis of the Clavicle

10:30AM-12:30PM: Abstract Number: 1955

Ultrasound for Screening of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review and Meta Analysis

10:30AM-12:30PM: Abstract Number: 1962

Utility of 18 FDG-PET/CT Scans in the Diagnosis of Polyarteritis Nodosa and Other Medium Vessel Vasculitis

10:30AM-12:30PM: Abstract Number: 1970

Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology: Interim Analysis for Enthesitis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].